Wednesday broker round-up
5th Sep 2012 09:20
AMEC: Nomura retains buy rating and 1,240p target. Ashtead: UBS ups target from 340p to 375p, buy rating unchanged. ASOS: Oriel Securities upgrades to buy; BarCap upgrades to overweight, target lifted rom 1,800p to 2,400p. BP: Investec keeps buy rating and 460p target. BT Group: JPMorgan Cazenov
Read moreCraneware revenues up on US healthcare cost pressures
4th Sep 2012 09:52
UK-listed but US-focused healthcare software provider Craneware is benefiting from the cost pressures on American hospitals. The company, which provides monitoring and automated revenue systems, has reported revenues of $41.1m in the 12 months to the end of June, a rise of 8% on the prior year. Ad
Read moreCraneware sees lower than expected full year earnings
2nd Jul 2012 07:42
US healthcare software developer Craneware said adjusted EBITDA will be below current market expectations for the year. The board expects to report revenue for the year in the region of $41m compared to $38.1m the year before. Adjusted EBITDA rose 15% from the previous year's figure of $10.1m. Thi
Read moreMonday broker round-up
11th Jun 2012 09:37
Antofagasta: RBS Capital Markets downgrades to underperform. Ashtead: Jefferies keeps buy recommendation and 300p target. Barclays: Bank of America Merrill Lynch keeps buy rating and 370p target; Oriel Securities reiterates buy recommendation and 285p target. BP: Nomura retains neutral stance and
Read moreCraneware turns heads on huge share price jump
28th Feb 2012 11:50
The share price of Craneware took flight and moved away from its 52-week low after the software supplier to the US health-care market announced a new contract win. The deal will see an unnamed "channel supplier" pay Craneware $7.5m between now and June 30th, 2014, in exchange for multi-year licence
Read moreCraneware plunges on downgrades
10th Jan 2012 16:36
Shares in Scotland-based software developer Craneware nose-dived more than 30%, or 170p, after both Investec and Brewin Dolphin downgraded the firm from buy to hold. The brokers' decisions came despite a 12% increase in first half year revenue from $16.6m. The results include, for the first time,
Read moreWednesday tips round-up: Johnson Matthey, Smiths Group, Headlam...
20th Jul 2011 06:49
Johnson Matthey's investors have become accustomed to the company making all the right noises when it updates the market. And yesterday it did not disappoint, writes the Independent. The speciality chemicals operation, which refines platinum and is the world's biggest maker of catalytic converters,
Read moreSales growth continues at Craneware
19th Jul 2011 07:52
Scotland-based software developer Craneware said revenue for the year ended 30 June 2011 is expected to have grown by 34% from $28.4m in 2010. The group, which provides revenue calculating software to US hospitals, said it is trading in line with company forecasts as it closed the year on strong f
Read moreNorth America boss offloads Pearson shares
2nd Mar 2011 17:47
Will Ethridge, chief executive of Financial Times publisher Pearson's North American education division, has sold a big chunk of shares in the company. He disposed of 33,000 American Depositary Receipts (ADRs) for $16.83 (£1,033p) a time or a total of nearly £350,000. News of the share sale comes
Read moreAnglo American boss digs deep again
28th Feb 2011 17:57
Anglo-American's chairman Sir John Parker has added to his stake in the company again with the purchase of nearly £100,000 in shares. He bought 2,890 at 3,282.5p a time. Last week he bought 3,000 at 3,238p each. Anglo American announced earlier this month that it is merging its UK cement, aggregat
Read moreStrong sales pipeline for Craneware
28th Feb 2011 08:17
Scotland-based Craneware, which provides revenue assessing software to US hospitals, continues its impressive growth in the six months to December 2010. AIM-quoted Craneware increased its rate of growth in the first half and continued to generate cash. Revenues grew by one-quarter to $16.6m with
Read moreCraneware's SaaS buy
18th Feb 2011 17:49
AIM-quoted Craneware is paying an initial $15m for ClaimTrust. The maximum consideration could be $19.5m. More than two-third's of ClaimTrust's $8.5m of annual revenues are recurring. Craneware is based in Scotland but all of its revenues are in the US. It supplies software that enables hospital
Read moreBumper first half for Craneware
25th Jan 2011 15:50
AIM-quoted Craneware, which provides revenue calculating software to US hospitals, says that its interim profit is set to grow by more than one-third. Revenues are 24% ahead at $16.6m in the six months to December 2010, while EBITDA is likely to be 35% higher at $4.6m. Broker Evolution says that
Read moreSmall caps round-up: Augean, Juridica, Origo...
28th Sep 2010 14:37
Waste group Augean slipped into a loss of £0.5m in the half year to June, as net revenue fell by 8% to £13.8m. "Trading in the months since the period end has indicated an improving trend as the early signs of a recovery in our markets have continued," it added. Legal case investor Juridica's net
Read moreEuropean Nickel non-exec buys
9th Sep 2010 17:01
European Nickel non-exec Neil Herbert has invested £216,000 in the nickel miner and explorer which recently merged with fellow AIM-quoted explorer Rusina Mining. Herbert bought 900,000 shares at 24p a share, which gives him 0.39% of the company. The shares were trading at below 24p each prior to t
Read more